These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
365 related items for PubMed ID: 9872657
1. In vivo cyclin E expression as a marker for early cervical neoplasia. Quade BJ, Park JJ, Crum CP, Sun D, Dutta A. Mod Pathol; 1998 Dec; 11(12):1238-46. PubMed ID: 9872657 [Abstract] [Full Text] [Related]
2. Ki-67, cyclin E, and p16INK4 are complimentary surrogate biomarkers for human papilloma virus-related cervical neoplasia. Keating JT, Cviko A, Riethdorf S, Riethdorf L, Quade BJ, Sun D, Duensing S, Sheets EE, Munger K, Crum CP. Am J Surg Pathol; 2001 Jul; 25(7):884-91. PubMed ID: 11420459 [Abstract] [Full Text] [Related]
3. p16(INK4a) as a complementary marker of high-grade intraepithelial lesions of the uterine cervix. I: Experience with squamous lesions in 189 consecutive cervical biopsies. Dray M, Russell P, Dalrymple C, Wallman N, Angus G, Leong A, Carter J, Cheerala B. Pathology; 2005 Apr; 37(2):112-24. PubMed ID: 16028838 [Abstract] [Full Text] [Related]
5. Loss of cytokeratin 14 expression is related to human papillomavirus type and lesion grade in squamous intraepithelial lesions of the cervix. Southern SA, McDicken IW, Herrington CS. Hum Pathol; 2001 Dec; 32(12):1351-5. PubMed ID: 11774168 [Abstract] [Full Text] [Related]
11. Expression of the 67 KD laminin receptor in human cervical preneoplastic and neoplastic squamous epithelial lesions: an immunohistochemical study. al-Saleh W, Delvenne P, van den Brule FA, Menard S, Boniver J, Castronovo V. J Pathol; 1997 Mar; 181(3):287-93. PubMed ID: 9155714 [Abstract] [Full Text] [Related]
12. TOP2A/MCM2, p16INK4a, and cyclin E1 expression in liquid-based cytology: a biomarkers panel for progression risk of cervical premalignant lesions. Del Moral-Hernández O, Hernández-Sotelo D, Alarcón-Romero LDC, Mendoza-Catalán MA, Flores-Alfaro E, Castro-Coronel Y, Ortiz-Ortiz J, Leyva-Vázquez MA, Ortuño-Pineda C, Castro-Mora W, Illades-Aguiar B. BMC Cancer; 2021 Jan 07; 21(1):39. PubMed ID: 33413211 [Abstract] [Full Text] [Related]
13. Staining characteristics of p16INK4a: is there a correlation with lesion grade or high-risk human papilloma virus positivity? Ozgul N, Cil AP, Bozdayi G, Usubutun A, Bulbul D, Rota S, Kose MF, Biri A, Haberal A. J Obstet Gynaecol Res; 2008 Oct 07; 34(5):865-71. PubMed ID: 18958930 [Abstract] [Full Text] [Related]
14. Evaluation of p16/Ki-67 dual staining in detection of cervical precancer and cancers: a multicenter study in China. Yu LL, Chen W, Lei XQ, Qin Y, Wu ZN, Pan QJ, Zhang X, Chang BF, Zhang SK, Guo HQ, Qiao YL. Oncotarget; 2016 Apr 19; 7(16):21181-9. PubMed ID: 27029033 [Abstract] [Full Text] [Related]
15. Expression of Yes-associated protein in cervical squamous epithelium lesions. Xiao H, Wu L, Zheng H, Li N, Wan H, Liang G, Zhao Y, Liang J. Int J Gynecol Cancer; 2014 Nov 19; 24(9):1575-82. PubMed ID: 25304677 [Abstract] [Full Text] [Related]
16. Assessment of correlation between p16INK4a staining, specific subtype of human papillomavirus, and progression of LSIL/CIN1 lesions: first comparative study. Razmpoosh M, Sansregret A, Oligny LL, Patey N, Dormoy-Raclet V, Ducruet T, Bouron-Dal Soglio D. Am J Clin Pathol; 2014 Jul 19; 142(1):104-10. PubMed ID: 24926093 [Abstract] [Full Text] [Related]
17. bcl-2 immunoreactivity, human papillomavirus DNA, and cervical intraepithelial neoplasia. Cooper K, Haffajee Z, Taylor L. Mod Pathol; 1999 Jun 19; 12(6):612-7. PubMed ID: 10392638 [Abstract] [Full Text] [Related]